Skip to main content
TipRanks
Go Ultimate75% OFF

Zinzino AB (ZZ.B) AI Stock Analysis

6 Followers
SE:ZZ.B

Zinzino AB

(Nasdaq OMX AB:ZZ.B)

Select Model
Rating:68Neutral
Price Target:SEK 126.00â–²(6.33% Upside)
Action:downgraded
Date:11/05/26

The company's financial health is a major strength, with explosive growth, a fortress balance sheet, and excellent cash flow. This is significantly offset by extremely weak technicals, as the stock is in a clear downtrend and deeply oversold. The attractive valuation, featuring a low P/E and high dividend yield, provides a partial counterbalance, but the current market momentum is a substantial headwind.

Positive Factors
Revenue GrowthMeaningful revenue expansion indicates that Zinzino is increasing the scale of its wellness-product business and reaching more customers through its operating model. If growth persists, the larger revenue base can support continued investment, improve operating leverage, and reinforce the company’s market position over the next several quarters.
Negative Factors
Margin VolatilityUneven gross-margin performance makes the current profitability level less predictable and weakens confidence in its durability. If margins normalize below the TTM level, revenue growth may translate into less operating profit and cash generation, limiting the benefit of Zinzino’s expanding scale.

Zinzino AB (ZZ.B) vs. iShares MSCI Sweden ETF (EWD)

-30%-20%-10%0%10%20%30%SE:ZZ.B-21.44%EWD+16.08%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
SEK 387.06M
Dividend Yield
5.06%
Average Volume (3M)
75.35K
Price to Earnings (P/E)
9.9
Beta (1Y)
0.74
Revenue Growth
26.78%
EPS Growth
74.48%
Country
Sweden
Employees
370
Sector
Consumer Defensive
Sector Strength
62
Industry
Packaged Foods

Zinzino AB Business Overview & Revenue Model

Company Description

Operating as a direct sales enterprise, Zinzino AB (publ) markets and distributes a comprehensive selection of nutritional supplements, coffee products, coffee machines, and associated accessories. The company's diverse offerings encompass health-foc...

How the Company Makes Money

Zinzino makes money primarily by selling its health and wellness products to end customers through a direct-sales (network marketing) model. Revenue is generated from: (1) Product sales: the core of revenue comes from selling nutritional supplements...

Zinzino AB Financial Statement Overview

Summary

Financial performance is exceptional, driven by explosive revenue growth, a pristine balance sheet with negligible debt, and robust cash flow generation with near-perfect conversion. Returns on equity are consistently high, indicating efficient capital use.

Income Statement

78Positive

Balance Sheet

85Very Positive

Cash Flow

82Very Positive
Financial statement breakdown
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue3.63B3.17B2.21B1.76B1.36B1.29B
Gross Profit1.09B272.48M732.48M645.93M378.45M345.39M
EBITDA531.50M305.82M253.59M245.88M117.02M137.95M
Net Income423.29M324.32M169.17M163.74M67.70M86.20M
Balance Sheet
Total Assets2.23B1.75B1.21B842.13M651.25M605.21M
Cash, Cash Equivalents and Short-Term Investments841.99M771.00M463.05M321.24M161.88M235.73M
Total Debt62.22M41.99M46.06M61.38M49.58M38.94M
Total Liabilities1.15B1.05B818.94M578.34M490.88M453.49M
Stockholders Equity1.08B707.20M386.14M259.97M154.45M143.05M
Cash Flow
Free Cash Flow681.34M529.96M295.19M234.36M17.92M143.82M
Operating Cash Flow688.13M541.87M309.11M246.14M42.86M153.49M
Investing Cash Flow-14.75M-91.91M-98.67M-11.92M-35.42M-11.98M
Financing Cash Flow-241.13M-113.12M-68.63M-74.87M-81.28M-49.00M

Zinzino AB Technical Analysis

Technical Analysis SentimentNegative
Last Price118.50

Price Trends

50DMA131.68Negative
100DMA132.55Negative
200DMA133.43Negative

Market Momentum

MACD-5.89Positive
RSI39.01Neutral
STOCH26.36Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SE:ZZ.B, the sentiment is Negative. The current price of 118.50 is below the 20-day moving average (MA) of 126.05, below the 50-day MA of 131.68, and below the 200-day MA of 133.43, indicating a bearish trend. The MACD of -5.89 indicates Positive momentum. The RSI at 39.01 is Neutral, neither overbought nor oversold. The STOCH value of 26.36 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for SE:ZZ.B.

Zinzino AB Peers Comparison

Overall Rating

UnderperformOutperform
Sector (62)

Financial Indicators

SE:ZZ.B against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
SE:CLA.BSE:CLA.B74OutperformSEK 18.00B19.4815.30%2.25%0.98%26.84%
SE:ZZ.BSE:ZZ.B68NeutralSEK 4.67B9.8648.04%5.06%26.78%74.48%
SE:MSON.BSE:MSON.B67NeutralSEK 1.38B8.315.43%2.32%-1.42%―
Sector *62Neutral$20.33B14.63-3.31%3.23%1.93%-12.26%
SE:SECARESE:SECARE60NeutralSEK 3.20B37.871.24%1.37%2.73%36.67%
SE:HUMBLESE:HUMBLE52NeutralSEK 2.75B-6.02-9.80%―3.05%-1130.58%
SE:NNHSE:NNH51NeutralSEK 96.03M20.95―1.61%2.70%-43.94%

* Consumer Defensive Sector Average

Performance Comparison

0%50%SE:ZZ.BSE:CLA.BSE:MSON.BSE:SECARESE:HUMBLESE:NNHDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
SE:ZZ.B and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
SE:ZZ.BZinzino AB Class B118.50-38.29-24.42%
SE:CLA.BCloetta AB Class B62.3527.2277.47%
SE:MSON.BMidsona AB Class B9.481.0111.92%
SE:SECARESwedencare AB20.45-15.47-43.07%
SE:HUMBLEHumble Group AB6.18-1.28-17.16%
SE:NNHNew Nordic Healthbrands AB15.50-6.34-29.04%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Nov 05, 2026